Keith Lipman

Direktor/Vorstandsmitglied bei Thirty Holdings Ltd.

53 Jahre

Technology Services

Commercial Services

Profil

Keith Lipman has held positions as a Director at MedAnnex Ltd.
and as a Group Executive Director at Thirty Holdings Ltd.

Unternehmen	Position	Beginn
Thirty Holdings Ltd. Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood.	Direktor/Vorstandsmitglied	01.01.2019
MedAnnex Ltd. MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.	Direktor/Vorstandsmitglied	-

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Private Unternehmen	2
Thirty Holdings Ltd. Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood.	Technology Services
MedAnnex Ltd. MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.	Commercial Services